Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 49 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 3 X users, with an upper bound of 27,867 followers.

Now #SITC21! #RapidOralClin Targeting metastatic, castration-resistant prostate cancer with DNA vaccine with pembrolizumab combination in a phase-2 study. McNeel et al @UWCarbone - Check out previous work in #JITC archives https://t.co/Oy48KJ1OBD JITC SM @

13 Nov 2021

Reply Repost Favourite

RT @sitcancer: #JITC Research Article: Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castr…

30 Mar 2018

Reply Repost Favourite

#JITC Research Article: Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine https://t.co/uRF6xADdS9 https://t.co/xlFtPAguTw

29 Mar 2018

Reply Repost Favourite

RT @sitcancer: #JITC Research Article: Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castr…

22 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.